ArticlePLoS medicine2026
Maternal congenital heart disease and risk of child developmental vulnerability in early school age: A population-based cohort study.
Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal congenital heart disease: Implications for the next generation.PLoS medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile maternal congenital heart disease (CHD) is associated with increased risks of adverse pregnancy outcomes, its impact on long-term child development remains unknown. This study aimed to investigate if in-utero exposure to maternal CHD is associated with child developmental vulnerability at school entry. METHODS AND
findingsThis population-based cohort study included 256,629 singleton offspring born in British Columbia, Canada between January 1, 1995 and December 31, 2016, with follow up through linkage to teacher-rated Early Development Instrument (EDI) surveys administered in kindergarten around 5-6 years of age. Over 90% children enrolled in participating schools completed the questionnaire. Developmental vulnerability was defined as a score <10th percentile in any two of the five EDI domains: physical health and wellbeing, social competence, emotional maturity, language and cognitive development, and communication and general knowledge. The association between maternal CHD and child developmental vulnerability was examined using modified Poisson regression models, adjusted for maternal age at delivery, parity, country of birth, marital status, neighborhood income quintiles, preexisting psychiatric disorders, and pre-gestational diabetes. A counterfactual four-way decomposition method was used to quantify potential mediation and moderation by preterm birth. Of the 256,629 children (51.4% female) included in the analysis, 456 (0.2%) were exposed to maternal CHD. Developmental vulnerability was identified among 25.2% children exposed to maternal CHD compared with 16.6% among the unexposed. In the adjusted model, maternal CHD was associated with 28% higher risk of developmental vulnerability (aRR 1.28; 95% CI [1.11, 1.48]) compared with no maternal CHD. The increased risk was observed across multiple developmental domains related to physical health and wellbeing (aRR 1.31; 95% CI [1.11, 1.54]), social competence (aRR 1.22; 95% CI [1.02, 1.45]), language and cognitive development (aRR 1.39; 95% CI [1.13, 1.70]), and communication and general knowledge (aRR 1.33; 95% CI [1.09, 1.63]). Preterm birth mediated only about 8% of the overall association. Severe CHD was more strongly associated with developmental vulnerability (aRR 1.98; 95% CI [1.31, 3.00]) compared to mild CHD (aRR 1.19; 95% CI [1.00, 1.42]). However, the study had limited capacity to separate intrauterine effects from potential genetic and postnatal familial influences. Some degree of CHD misclassification is possible, which would likely bias the association toward the null.
conclusionsIn this population-based study, maternal CHD was associated with child developmental vulnerability at school entry. While further research is required to elucidate the mechanisms, enhanced clinical monitoring and tailored support to reproductive age women with CHD may help reduce the risk of developmental vulnerability in their children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.